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Abstract 
We examine the relationship between body mass index (BMI) and mental health for young adults and 
elderly individuals using data from the National Longitudinal Study of Adolescent Health and the Health 
& Retirement Study. While ordinary least squares (OLS) estimates show that BMI is significantly 
associated with worse mental health in both young adulthood and old age, they are likely to be 
confounded by (i) unobserved factors that affect both BMI and mental health and (ii) reverse causality. 
To tackle confounding, we take two complementary approaches. First, we use a polygenic score for 
BMI as an instrumental variable (IV) and adjust for polygenic scores for other factors that may 
invalidate this IV. The IV estimates indicate that there is no statistically significant relationship between 
BMI and mental health for young adults, whereas there is a positive and statistically significant 
relationship for the elderly. Moreover, we show that IV estimates likely have to be interpreted as 
identifying a weighted average of effects of BMI on mental health mostly for individuals on the upper 
quantiles of the BMI distribution. Given potential remaining concerns about the validity of the IV, our 
second approach is to consider it an “imperfect” IV and estimate an upper bound on the average 
treatment effect for the corresponding population following Nevo & Rosen (2012). The estimated 
upper bounds reinforce the conclusions from the IV estimates: they show little evidence of a 
detrimental effect of BMI on mental health for young adults while being consistent with an 
economically meaningful effect for elderly individuals. Lastly, we explore some of the potential channels 
through which BMI may affect mental health for the elderly. 
JEL No.  I10, I12 
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1. Introduction 
 Mental health is an important public health issue in the US because of the high prevalence of 
mental illnesses, and the associated economic and societal costs. In any given year, approximately 18.5% 
of US adults suffer from a mental illness (National Alliance on Mental Illness). Mental illnesses hasten 
mortality by 10-20 years, (Chesney et al. 2014), and are linked to diabetes, heart disease, strokes, and 
suicide, which in turn led to the decrease in US life expectancy in 2016 (Kochanek et al. 2017). 
  Poor mental health is a multifactorial problem. Although there is no single solution, one well-
known risk factor is body mass. Several studies have shown that individuals who have a high BMI or are 
obese are more likely to have poor mental health and be depressed (Carpenter et al. 2000; Luppino et al. 
2010; Ha et al. 2017; Roberts et al. 2000; Rosen-Reynoso 2011; Scott et al. 2008; Simon et al. 2006; 
Zhao et al. 2009). Biologically, there is a relationship between BMI and mental health, because obesity is 
associated with chronic low-grade inflammation in peripheral tissues and blood circulation (Gregor & 
Hotamisligil 2011). Inflammation in turn affects brain physiology, and alters mood and behavior leading 
to depression (Miller & Raison 2016). Markowitz et al. (2008) suggest that the relationship may also be 
due to behavioral mechanisms (functional impairment), cognitive mechanisms (body image 
dissatisfaction, poor self-reported health), and social mechanisms (stigma). There is a stigma associated 
with obesity. Obese individuals are viewed as being lazy, unintelligent, unsuccessful, and lacking self-
discipline (Puhl & Heuer 2010). These stereotypes can lead to actual and/or perceived discrimination, 
low self-esteem and depression (Kessler et al. 1999). Discrimination stemming from obesity can also lead 
to depression through the labor market, to the extent that obesity is associated with worse labor market 
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outcomes, which in turn can lead to financial stress and depression1. Poor self-reported health can 
contribute to depression through a cognitive mechanism, because individuals who believe their health to 
be poor may also hold other depressive beliefs. The relationship can also run through functional 
impairments and exercise. Obesity is associated with a higher probability of experiencing limitations in 
carrying out activities of daily living (Himes 2000). Functional limitations affect one’s ability to 
undertake physical exercise, which is associated with better mental health (Paolucci et al. 2018). 
  Although there are empirical associations, and theoretical reasons for BMI affecting mental 
health, it is unclear whether there is a causal relationship. First, the causal relationship could be 
confounded by unobserved factors (e.g. time preference, genetic endowments, innate ability) that affect 
both BMI and mental health. Second, there is a problem of reverse causality insofar as poor mental health 
is associated with a higher likelihood of being obese. To tackle confounding, some recent studies have 
employed a polygenic score (PGS) for BMI as an instrumental variable (IV). A PGS is a summary measure 
of an individual’s genetic predisposition for a given trait, and is constructed using results from Genome 
Wide Association Studies (GWAS). In a GWAS, hundreds of thousands of single nucleotide 
polymorphisms (SNPs) are tested for associations with an outcome2. As an example, Speliotes et al. 
(2010) conducted a GWAS on a sample of 123,864 individuals, where they examined associations 
between 2.8 million SNPs with BMI. They identified 32 SNPs that reached genome-wide significance 
(p<5x10-8), which explain approximately 1.45% of the variation in BMI. A PGS for BMI is constructed 
                                                          
1 Studies have found that a higher BMI/obesity is associated with a lower probability of being employed and lower wages 
(Brunello & D’Hombres 2007; Greve 2008; Morris 2007). 
2 A SNP is a DNA sequence variation occurring when a single nucleotide (A, T, C or G) in the genome differs at a single position 
among individuals. 
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by aggregating the SNPs identified in Speliotes et al. (2010) and weighting them by the strength of their 
association.3 
  Previous studies have used as an IV a PGS consisting of 32 SNPs identified as genome-wide 
significant predictors of BMI in the GWAS by Speliotes et al. (2010)4. IV estimates for US based studies 
show that there is no statistically significant relationship between BMI and mental health. Hung et al. 
(2014) estimate the effect of BMI on the probability of major depressive disorder in young adults 
(average age of 26 years) using data from RADIANT. Walter et al. (2015) estimate the effect of BMI on 
depression for women (with an average age of 56 years) using data from the Nurses’ Health Study. 
Willage (2018) estimates the effect of BMI on depression in young adults (18-34 years of age) using the 
siblings sample in the National Longitudinal Study of Adolescent Health. In all three studies, the OLS 
estimates showed a positive statistically significant association between BMI and mental health, whereas 
IV estimates were statistically insignificant. Willage (2018) does however find that BMI is associated 
with suicidal ideation. In contrast to US results, Jokela et al. (2012) find that a higher BMI is associated 
with worse mental health in adolescents and adults in Finland. Tyrrell et al. (2018) use a PGS consisting 
of 73 SNPs from those identified in the more recent GWAS by Locke et al. (2015)5. The IV estimates in 
Tyrrell et al. (2018) show a significant positive association between BMI and depression for individuals 
(average age of 57 years) in the UK. 
                                                          
3 The PGS for individual i is a weighted average across the number of SNPs (n) of the number of reference alleles A (0, 1 or 2) 
at that SNP multiplied by the corresponding beta estimate from the GWAS analysis: 𝑃𝑃𝑃𝑃𝑃𝑃𝑖𝑖  = ∑ 𝛽𝛽𝑛𝑛𝑗𝑗=1 𝑗𝑗  𝐴𝐴𝑖𝑖𝑗𝑗 . However, in 
practice constructing PGSs involves several complex decisions such as whether the PGS should be limited to genome-wide 
significant SNPs or whether a series of more liberal thresholds should be applied (e.g., p<0.001, 0.01). See Ware et al. (2017) 
for a detailed overview of the decisions involved in constructing GRSs.   
4 In the economics literature, a PGS for BMI has also been used as an IV to estimate effects of BMI on labor market outcomes 
(Böckerman et al. 2019) and on academic performance and blood pressure (von Hinke et al. 2016). 
5 Locke et al. (2015) identified 97 SNPs (of which 56 are novel) as genome-wide significant predictors of BMI, which explain 
about 2.7% of the variation in BMI. 
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We contribute by examining the relationship between BMI and mental health (measured using 
the Center for Epidemiologic Studies Depression Scale; CES-D) for two important groups: young adults 
(aged 25-34 years from the National Longitudinal Study of Adolescent Health) and elderly individuals 
(aged 50-89 years from the Health & Retirement Study), using genetic data to form the IV. The 
comparison between young adults and the elderly is interesting because some studies (Crisp et al. 1980; 
Palinkas et al. 1996) have found a protective effect (often termed the Jolly Fat Hypothesis) of 
BMI/obesity on mental health. Like previous studies, notably Willage (2018) who also analyzed a 
sample of young adults from the National Longitudinal Study of Adolescent Health, we also use genetic 
data to form an IV, but there are two key differences in our study and approach6. First, our PGS is more 
powerful as it is based on the more recent Locke et al. (2015) GWAS, and includes all SNPs. A PGS that 
includes all SNPs has more predictive power than one that is just based on genome wide significant SNPs 
(Ware et al. 2017). Second, one concern with using a PGS as an IV is that it may violate the exclusion 
restriction because of pleiotropy (von Hinke et al., 2016; van Kippersluis and Rietveld, 2017; DiPrete et 
al, 2018); that is, that the PGS for BMI may affect mental health independently of its effect on BMI 
because genes associated with BMI may be related to other genes or traits that also affect mental health. 
We address this potential concern in two separate ways. First, by using a PGS for depression to control 
for the genetic predisposition to poor mental health, and a PGS for educational attainment to control for 
innate ability. We find that the IV estimates for the elderly are likely overestimated if we do not control 
for these PGSs. Second, we regard the PGS for BMI as a potentially “imperfect IV” (Nevo & Rosen, 2012) 
                                                          
6 An additional important difference between our analysis of young adults and Willage (2018) is that he uses the siblings 
sample from the National Longitudinal Study of Adolescent Health, while we use a more general sample described in section 
2.1. 
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in the sense that it is allowed to violate the exclusion restriction, and estimate an upper bound for the 
effect of BMI on mental health in the corresponding population.  
Overall, the IV estimates indicate that there is no statistically significant relationship between 
body mass and mental health for young adults, whereas there is a positive, substantial, and statistically 
significant relationship for the elderly. For the latter group, a 5 kg/m2 increase in BMI is related to a 20% 
increase in their CES-D score, and a 29% increase in the likelihood of depression. We stress that IV 
estimates are not directly comparable to OLS estimates. In the presence of heterogeneous effects, IV 
methods identify a local average treatment effect (LATE) for those individuals whose BMI is affected by 
the PGS for BMI (the so-called “compliers”; Imbens & Angrist, 1994). In contrast, OLS estimates, under 
strong assumptions such as unconfoundedness, identify the average treatment effect for the 
corresponding population (young adults or the elderly). Using unconditional quantile treatment effects 
estimates of the relationship between the BMI PGS and BMI, we document that using a BMI PGS as an 
instrument likely identifies a weighted average of effects for those individuals whose BMI is affected by 
their BMI PGS (compliers), with the weights being higher for individuals in the upper quantiles of the BMI 
distribution. 
To complement the IV analysis, we estimate an upper bound on the average treatment effect for 
the corresponding population following Nevo & Rosen (2012). Their approach combines the use of an 
“imperfect” IV (in our case, the BMI PGS) with relatively weak assumptions about the direction (and in 
some cases relative magnitude) of the correlation between the IV and unobserved factors in the OLS 
model for mental health, and the correlation between those same unobserved factors and the 
endogenous regressor (BMI). The estimated upper bounds are largely consistent with the conclusions 
gathered using the IV estimates. They are consistent with the effects of BMI on mental health for young 
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adults being at most small and economically insignificant, and they are consistent with economically 
significant effects for the elderly population. 
The paper is organized as follows. We describe the datasets and outline the econometric 
approaches in sections 2 and 3, respectively. The results are presented and discussed in section 4. Finally, 
section 5 concludes. 
2. Data 
We employ data from two sources: the National Longitudinal Study of Adolescent Health (Add 
Health) and the Health & Retirement Study (HRS). The first data focuses on young adults, while the 
second focuses on the elderly.  
2.1 The National Longitudinal Study of Adolescent Health (Add Health) 
Add Health is a nationally-representative sample of 20,745 students in grades 7 through 12 
(aged 12-21) in 1994-95 (wave 1). Adolescents were surveyed from 132 schools that were selected to 
ensure representativeness with respect to region, urbanicity, school size and type, and ethnicity. In wave 
1, data were collected from adolescents, their parents, siblings, friends, relationship partners, fellow 
students, and school administrators. The adolescents have been followed 1 year (wave 2, 1996), 6 years 
(wave 3, 2001-2002), and 13 years (wave 4, 2008) later.  
We examine the relationship between BMI and mental health at wave 4, which corresponds to 
the wave when genetic data were collected. BMI (weight kg/ height m2) is based on measurement taken 
by field interviewers as part of data collection. Mental health is measured using the 10 item CES-D. The 
CES-D score is created by summing responses (ranging from 0 to 3) from questions that asked 
respondents how often in the last week they (1) were bothered by things not normally bothersome; (2) 
could not shake the blues; (3) felt like they were not as good as others; (4) had trouble focusing; (5) were 
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depressed; (6) were too tired to do things they enjoyed; (7) felt sad; (8) felt happy; (9) enjoyed life, and 
(10) felt disliked. Hence, the CES-D score has ranges from 0 to 30, with higher values corresponding to 
poorer mental health. Depression is defined as having a score of 11 or higher (Suglia et al. 2016). 
At wave 4 96% of participants consented to providing saliva samples. Approximately 12,200 
(80% of those participants) consented to long-term archiving and were consequently eligible for 
genome-wide genotyping. Genotyping was done on two Illumina platforms, with approximately 80% of 
the sample genotyping performed with the Illumina Omni1-Quad BeadChip and 20% genotyped with 
the Illumina Omni2.5-Quad BeadChip. After quality control procedures, genotyped data are available 
for 9,974 individuals (7,917 from the Omni1 chip and 2,057 from the Omni2 chip) on 609,130 SNPs 
common across both genotyping platforms. Using this data, Add Health has released PGSs for 9,129 
individuals. Of these 9129 individuals, 63% (5728 individuals) are of European ancestry. We 
concentrate on individuals of European ancestry because the GWAS we employ is for this population, 
and the PGSs for other ethnic groups may not have the same predictive power (Martin et al. 2017). Our 
instrument is a PGS for BMI, which is based on the GWAS by Locke et al. (2015). We use as controls a 
PGS for educational attainment, which is based on the GWAS by Lee et al. (2018), and a PGS for major 
depressive disorder based on the GWAS by Wray et al. (2018). We do this to increase the plausibility 
of the exclusion restriction assumption of the IV  by controlling for factors that have the potential to be 
simultaneously related to mental health and the PGS for BMI, such as innate ability and genetic 
predisposition of depression. All PGSs provided by Add Health are standardized to have a mean of 0 and 
a standard deviation of 1. 
The final sample consists of 4,928 European ancestry respondents with non-missing information 
on BMI, mental health, the PGSs, and a set of basic control variables (age, gender, birth order, mother’s 
education, picture vocabulary score, PGS for education and PGS for depression). 
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2.2 Health & Retirement Study (HRS) 
The HRS is a nationally-representative longitudinal survey of more than 37,000 individuals in 
23,000 households over age 50 in the US. The HRS started in 1992 and data is collected every 2 years 
on income and wealth, health, cognition, use of health care services; work and retirement, and family 
connections. The initial HRS cohort consisted of persons born 1931-41 (then aged 51-61) and their 
spouses of any age. A second study, Asset and Health Dynamics Among the Oldest (AHEAD) was fielded 
the next year to capture an older birth cohort, those born 1890-1923. In 1998, the 2 studies merged, 
and, in order to make the sample fully representative of the older US population, two new cohorts were 
enrolled, the Children of the Depression (CODA), born 1924-1930, and the War babies, born 1942-
1947. The HRS now employs a steady state design, replenishing the sample every six years with younger 
cohorts to continue making it fully representative of the population over age 50. 
Although the HRS began in 1992, collection of genetic data only started in 2006. Genotype data 
on over 19,000 HRS participants was obtained using the llumina HumanOmni2.5 BeadChips. The HRS 
recently released publicly available constructed PGSs for 12,090 European-ancestry individuals. We 
merge this genetic data to the RAND HRS dataset (version p), which is a cleaned and streamlined version 
of the HRS. We focus on the 2006 wave of the HRS, which consist of 18,469 individuals, as the genetic 
data was first collected in 2006. The RAND HRS contains a cleaned BMI variable, which is based on self-
reported height and weight. Mental health is based on an 8 item CES-D score, which is based on the 
following questions with “yes/no” response options: much of the time during the last week: (1) I felt 
depressed; (2) everything I did was an effort; (3) my sleep was restless; (4) I felt lonely; (5) I felt sad; (6) 
I felt happy; (7) I enjoyed life, and (8) I could not get going. The total number of “yes” responses are 
summed to calculate the CES-D score. Hence, the range of the CES-D measure in HRS is from 0 to 8, with 
higher values of the variable corresponding to poorer mental health. Individuals with a CES-D score of 4 
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or more are classified as being depressed (Steffick 2000). Like in Add Health, our instrument is a PGS for 
BMI based on the GWAS by Locke et al. (2015), and the PGS for educational attainment is based on the 
GWAS by Lee et al. (2018). The PGS for depression in the HRS is different from that in Add Health. The 
HRS provides a PGS for depressive symptoms, which is based on an auxiliary GWAS conducted by 
Okbay et al. (2016), as part of their subjective wellbeing GWAS. All PGSs are standardized to have a 
mean of 0 and a standard deviation of 1. Our final sample consist of 8,867 European ancestry individuals 
with non-missing information on BMI, mental health, the PGSs, and mother’s education. 
3. Methodology 
3.1 OLS and IV Estimation 
We first estimate associations between BMI and mental health through OLS regressions where 
the mental health of individual i (𝑀𝑀𝑀𝑀𝑖𝑖) is modelled as a linear function of BMI (𝐵𝐵𝑀𝑀𝐵𝐵𝑖𝑖), a vector of 
covariates (𝑋𝑋𝑖𝑖), and a stochastic error term (𝑢𝑢𝑖𝑖). 
(1) 𝑀𝑀𝑀𝑀𝑖𝑖 = 𝛽𝛽0 + 𝛽𝛽𝐵𝐵𝑀𝑀𝐵𝐵𝑖𝑖 +  𝑋𝑋𝑖𝑖′𝛿𝛿 + 𝑢𝑢𝑖𝑖  
Our parameter of interest in this case is 𝛽𝛽, which represents the association between BMI and mental 
health. However, this association is likely to be confounded by unobserved factors that are correlated 
with both BMI and mental health. If no such unobserved factors exist, the causal effect estimated is the 
population (from which the sample is drawn) average treatment effect. To circumvent the likely influence 
of unobserved factors (confounders), the first approach we employ is IV estimation using a PGS for BMI 
as an instrument for BMI7. IV estimation is equivalent to two stage least squares. In the first stage 
                                                          
7 The use of genetic variants as IVs is also known as Mendelian Randomization in the medical literature (von Hinke et al. 2016). 
The method exploits Mendel's law of independent assortment according to which a trait is inherited independently from other 
traits at conception. 
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(equation 2), the BMI of individual i is related to the PGS for BMI (𝑃𝑃𝑃𝑃𝑃𝑃𝑖𝑖 , which is standardized to have a 
mean of 0 and standard deviation of 1) and a vector of exogenous control variables (𝑋𝑋𝑖𝑖):  
(2)  𝐵𝐵𝑀𝑀𝐵𝐵𝑖𝑖 = 𝛼𝛼0 +  𝛾𝛾𝑃𝑃𝑃𝑃𝑃𝑃𝑖𝑖 + 𝑋𝑋𝑖𝑖′𝜓𝜓 +  𝑣𝑣𝑖𝑖  
To obtain the IV estimate of 𝛽𝛽, the second stage (equation 3) is performed by regressing mental health 
on the predicted BMI (𝐵𝐵𝑀𝑀𝐵𝐵𝚤𝚤� ) from equation (2) and a vector of control variables: 
(3) 𝑀𝑀𝑀𝑀𝑖𝑖 = 𝑐𝑐0 +  𝛽𝛽𝐼𝐼𝐼𝐼𝐵𝐵𝑀𝑀𝐵𝐵𝚤𝚤� +  𝑋𝑋𝑖𝑖′р + 𝜖𝜖𝑖𝑖  
Under heterogeneous effects, the IV estimates represent a Local Average Treatment Effect 
(LATE): the causal effect of the treatment on the outcome for “compliers”—those individuals whose BMI 
(treatment) is affected by the PGS for BMI (IV)—if the following assumptions hold (Imbens & Angrist, 
1994; Angrist et al., 1996): (A1) Random assignment of the instrument; (A2) Non-zero average effect 
of the instrument on the endogenous variable (BMI); (A3) monotonicity: that the instrument affects the 
endogenous variable in the same direction for all individuals; and (ER) The exclusion restriction: that the 
instrument affects the outcome only through its effect on the endogenous variable. 
Although genes are randomly inherited at conception conditional on parental genotype, 
assumption (A1) may fail because of population stratification. Population stratification refers to a 
situation where the distribution of genes systematically differs by population subgroups (e.g. by 
ethnicity/race). If these subpopulations also systematically have different health outcomes that are not 
due to genetic make-up, then this could lead to a spurious correlation between genetic risk and health. 
Population stratification can be controlled for by limiting analyses to ethnically homogenous samples 
(Cardon & Palmer 2003) and by including principal components from genome-wide SNP data as control 
variables, which account for genetic differences across ethnic groups (Price et al. 2006). We include the 
first 20 (10, respectively) principal components when using the Add Health (HRS) data to control for 
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population stratification and limit our analyses to individuals of European-ancestry8. Therefore, our 
analysis assumes the PGS is exogenous conditional on population stratification. Assumption (A2) can be 
empirically verified. Previous studies (e.g., Willage, 2018) have shown that the PGS for BMI is 
statistically significantly associated with BMI, and we show this is also the case in our samples in the next 
section. Assumption (A3) requires that increasing the number of risk alleles for an individual increases 
the exposure (BMI) or leaves it constant, but does not decrease it. In other words, this means that an 
individual who has genes related to BMI should have at least as high a BMI compared to if he/she did not 
have those genes. This assumption is untestable, but von Hinke et al. (2016) argue that it is likely to hold 
because genes are randomly assigned and individuals do not know their genotype, so they cannot act on 
knowledge of their genes in a way so as to violate the monotonicity assumption (e.g., being careless about 
their BMI if they do not have the gene and being over-reactive otherwise). Moreover, von Hinke et al. 
(2016) note that although the counterfactual is unobserved, studies have shown, at the population level, 
that individuals who have risk alleles have a higher BMI than those who do not, which is consistent with 
(A3). 
The ER assumption requires that the PGS for BMI affects mental health only through its effect on 
BMI. One important reason why the ER may be violated is because of pleiotropy (von Hinke et al., 2016; 
van Kippersluis and Rietveld, 2017; DiPrete et al, 2018). Genes have multiple functions (pleiotropy), 
and genes related to BMI may be related to other traits (e.g. smoking, education) that also affect mental 
health. A gene could also be related to another gene (through linkage disequilibrium) that directly affects 
mental health9. For example, if the FTO gene (that is associated with obesity) is also related to 
                                                          
8 The HRS only provides the first 10 principal components of the genetic data, whereas Add Health provides the first 20 
principal components.   
9  Linkage disequilibrium is the non-random association of alleles at different loci in a given population. 
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intelligence, which affects mental health, then the ER would be violated. Locke et al. (2015) manually 
reviewed the literature related to 405 genes within 500 kb and a r2>0.2. On a broad level, they found 
that genes effect BMI through hypothalamic function, energy homeostasis, and neuronal transmission 
and development. However, Locke et al. (2015) do report that some genes are associated with 
schizophrenia, smoking, and type 2 diabetes10. If these traits also affect mental health, then they 
represent paths—independent of BMI—through which the ER is violated. Our first strategy to deal with 
pleiotropy is quite straightforward. Two broad sources—other than BMI—through which the BMI PGS 
might affect mental health are through its relation to other genes that affect mental health or 
intelligence/cognitive ability. We use a PGS for depression to control for the genetic risk of having poor 
mental health, and a PGS for educational attainment to control for innate ability. The PGSs for mental 
health and educational attainment are correlated with the BMI PGS and mental health11. Hence, those 
two PGSs may also be related to mental health unobserved factors, in which case the ER assumption 
would be violated if they were not included as controls. This first strategy we employ is in the same spirit 
as the recent work by DiPrete et al. (2018), although it was not motivated by it. 
3.2 Nevo & Rosen (2012) Bounds 
The second strategy we employ to deal with potential violations of the ER—from pleiotropy or 
other sources—consists on estimating an upper bound for the corresponding population effect using the 
BMI PGS as a potentially “imperfect IV”. Nevo & Rosen (2012) derive bounds on the average treatment 
                                                          
10 The genes rs38888190, rs7903146, rs1558902, rs2176040, rs1558902 are associated with type 2 diabetes. 
rs11191560 is associated with schizophrenia, and rs11030104 is associated with smoking initiation. See Locke et al. (2015) 
supplementary table 17B.  
11 In Add Health: (1) the correlation (standard error) between the BMI and education PGSs is -0.1731 (0.014), and (2) the 
correlation (standard error) between the BMI and depression PGSs is 0.0322 (0.014). In the HRS: (1) the correlation 
(standard error) between the BMI and education PGSs is -0.1707 (0.011), and (2) the correlation (standard error) between 
the BMI and depression PGSs is -0.0152 (0.011). All correlations are statistically significant except for the correlation 
between the BMI and depression PGSs in the HRS. 
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effect in the original OLS model (𝛽𝛽 equation in (1)) using an IV that may or may not satisfy the ER. 
Instead, they maintain an assumption about the direction of the correlation between (i) the instrument 
(PGS for BMI) and the error term representing the outcome’s (mental health’s) unobserved factors, and 
(ii) the endogenous variable (BMI) and the same error term. Specifically, let 𝜌𝜌𝑎𝑎𝑎𝑎  denote the correlation 
between any two variables A and B, 𝜎𝜎𝑎𝑎𝑎𝑎  denote their covariance, and 𝜎𝜎𝑎𝑎  denote the standard deviation 
of A. Nevo & Rosen (2012) assume that: (A4) 𝜌𝜌𝑤𝑤𝑤𝑤𝜌𝜌𝑧𝑧𝑤𝑤 ≥ 0 (their “assumption 3”); that is, that the 
instrument (𝑧𝑧) has (weakly) the same direction of correlation with the error term 𝑢𝑢 as the endogenous 
variable 𝑤𝑤 (e.g. BMI). In our context, we presume that the leading mental health unobserved factors 
present in the error term are unobserved health endowments and environmental factors (e.g., 
unobserved family environment). It is also important to keep in mind that lower values of the CESD score 
measure better mental health (the same applies to the depression indicator). Thus, “better” mental health 
unobservables lead to lower values of CES-D and, correspondingly, lower values of the error term. Then, 
since we would expect individuals with better unobserved health endowments and/or environmental 
factors (and thus lower values of the error term) to have a lower BMI on average, we expect that BMI is 
positively correlated with the error term. Similarly, we also expect our instrument—genetic risk for high 
BMI—to be positively correlated with the error term under a similar reasoning. Nevo & Rosen (2012) 
show that if the instrument is positively correlated with the endogenous variable (𝜎𝜎𝑧𝑧𝑤𝑤 > 0), and if the 
instrument and endogenous variable are positively correlated with the error term (𝜎𝜎𝑤𝑤𝑤𝑤,𝜎𝜎𝑧𝑧𝑤𝑤 ≥ 0), then 
their bounds on 𝛽𝛽 only provide an upper bound: 
(4)   𝛽𝛽 ≤ min{𝛽𝛽𝑂𝑂𝑂𝑂𝑂𝑂,𝛽𝛽𝑧𝑧𝐼𝐼𝐼𝐼} 
where 𝛽𝛽𝑂𝑂𝑂𝑂𝑂𝑂 and 𝛽𝛽𝑧𝑧𝐼𝐼𝐼𝐼  denote the probability limits of the standard OLS and IV estimators for 𝛽𝛽, 
respectively.  
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 The bounds in (4) can be tightened by assuming that: (A5) the instrument (PGS for BMI) is less 
correlated with the error term in equation (1) than is the endogenous variable (BMI), i.e., |𝜌𝜌𝑤𝑤𝑤𝑤| ≥ |𝜌𝜌𝑧𝑧𝑤𝑤| 
(“assumption 4” in Nevo & Rosen 2012). Although this assumption is untestable, we believe that it is 
likely to hold in our context for two main reasons. First, our instrument comes from a genetic lottery, 
whereas BMI is a choice variable that is likely to be affected by many unobserved factors from birth until 
BMI is measured. Second, our instrument could be correlated with the error term because it could be 
correlated with other unobserved genes associated to mental health. However, we control for PGSs for 
education and depression, which should imply that our instrument is less correlated with the error term 
than if we did not control for these PGSs, making this assumption more plausible. 
The two previous assumptions give the definition of an “imperfect IV” in Nevo & Rosen (2012), 
as an IV that has the same direction of correlation with the unobserved error term as the “treatment” 
variable of interest (in our case BMI), but is less endogenous than the treatment variable. They define the 
function 𝑉𝑉(𝜆𝜆) = 𝜎𝜎𝑤𝑤𝑍𝑍 − 𝜆𝜆𝜎𝜎𝑧𝑧𝑊𝑊, which, when evaluated at 𝜆𝜆∗ =
𝜌𝜌𝑧𝑧𝑧𝑧
𝜌𝜌𝑤𝑤𝑧𝑧
, generates a variable that is 
uncorrelated with the error term, and thus serves as a valid instrument. Although 𝜆𝜆∗ is unknown, it is 
bounded between 0 and 1 under the assumptions above. Nevo & Rosen (2012) employ the bounds on 
𝜆𝜆∗ to bound 𝛽𝛽 in equation (1).  
For the linear regression model, Nevo & Rosen (2012) use 𝑉𝑉(1) = 𝜎𝜎𝑤𝑤𝑍𝑍 − 1𝜎𝜎𝑧𝑧𝑊𝑊 as the 
instrument. As it was the case before, if the instrument is positively correlated with the endogenous 
variable, and if the instrument and endogenous variables are positively correlated with the error term, 
then the Nevo & Rosen (2012) bounds on 𝛽𝛽 in equation (1) only provide an upper bound. This upper 
bound is given by: 
(5) 𝛽𝛽 ≤ min�𝛽𝛽𝐼𝐼(1)𝐼𝐼𝐼𝐼 ,𝛽𝛽𝑧𝑧𝐼𝐼𝐼𝐼� 
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where 𝛽𝛽𝐼𝐼(1)𝐼𝐼𝐼𝐼  is the probability limit of the standard IV estimator for 𝛽𝛽 when 𝑉𝑉(1) is used as an instrument 
for 𝑤𝑤. 
Being able to estimate an upper bound on 𝛽𝛽 in equation (1) is useful. The estimated upper bound 
provides a benchmark magnitude for the population average effect while relaxing the potentially 
troublesome ER. This magnitude can be directly compared to the estimates obtained from OLS, which 
identifies the same effect under strong conditions. It is also important to keep in mind that the effect that 
is bounded differs from the LATE identified by IV methods under the validity of the exclusion restriction. 
Therefore, it is misleading to interpret differences in the two approaches as violations of the ER, since the 
differences may be due to effect heterogeneity. Still, the comparison of the estimated upper bound with 
the estimated LATE can be informative about treatment effect heterogeneity if the ER assumption is 
maintained. Lastly, the upper bound allows ruling out plausible magnitudes for the true effect if they fall 
outside the bound and corresponding confidence interval. Unfortunately, in our setting the estimated 
upper bound is not useful for ruling out zero effects. 
4. Results 
Table 1 provides summary statistics for Add Health and HRS respondents. In Add Health, the 
average age at wave 4 is 28.94 years, and over half (54%) of respondents are female. The average BMI 
is 28.56 kg/m2. The mean CES-D score is 5.79, and 15% are classified as being depressed. Examining the 
summary statistics by gender reveals that women have substantially a higher CES-D score and incidence 
of depression, but there are no differences in BMI. The HRS respondents are 68.18 years old on average 
in 2006 and 58% are women. Average BMI is 27.69 kg/m2. The average CES-D score is 1.26, and 12% 
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are depressed12. In comparison to young adults, there are large gender differences in both BMI and 
mental health. On average, women have a slightly lower BMI but much higher CES-D scores and 
incidence of depression compared to men. 
4.1 OLS Estimates 
The OLS estimates for young adults are presented in Table 2 columns 1-3. Panel A shows 
estimates for the CES-D score and panel B for the depression indicator. All regressions control for a PGS 
for depression, PGS for educational attainment, age, age squared, gender, birth order, mother’s 
education, picture vocabulary score, and the first 20 ancestry-specific principal components of the 
genetic data.  There are three important points. First, the associations between BMI and mental health 
are relatively small. Column 1 shows that there is a small statistically significant positive association 
between BMI and the CES-D score. The coefficient on BMI indicates that a 5 kg/m2 increase in BMI is 
associated with a 0.14 unit increase in the CES-D score13,14. This represents an increase of 2.4%, given 
the mean CES-D score of 5.79. This means that BMI would have to increase by 10 kg/m2 (e.g. going from 
a BMI of 20 and being classified as “normal weight” to a BMI of 30 and being classified as “obese”) for 
the CES-D score to increase by 5%.  Similarly, the OLS estimate in panel B column 1 shows that a 5 kg/m2 
increase in BMI is associated with a 1 percentage point increase (6.67% off the mean) in the likelihood 
of depression. Second, there are statistically significant differences by gender. There is a positive 
association between BMI and the CES-D score for women. A 5 kg/m2 increase in BMI is associated with 
                                                          
12 Recall that the scale of the CES-D score in Add Health and HRS differ, with the first going from 0 to 30 and the second from 
0 to 8.  
13 A 5 kg/m2 increase in BMI would move an individual’s classification from overweight to obese. For example, for a man 
(women, respectively) with the average height for men (women) of 5 foot 9 inches (5 foot 3 inches), the weight corresponding 
to a 25 BMI would be 169 lbs (141 lbs). For him (her), a 5 kg/m2 increase in BMI would correspond to a 43 lbs (28 lbs) 
increase in weight. The average height of men and women are taken from Fryar et al. (2018).  
14 According to the Centers for Disease Control and Prevention, an adult person is classified as being underweight if his/her 
BMI is less than 18.5, of normal weight if his/her BMI is in the interval [18.5, 25), overweight if his/her BMI is in the interval 
[25, 30), and obese if his/her BMI is 30 or higher.  (https://www.cdc.gov/obesity/adult/defining.html). 
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a 0.31 unit (5%) increase in the CES-D score. In contrast, for men a 5 kg/m2 increase in BMI is associated 
with a decrease in the CES-D score by 0.014 units (2.5%).  Third, the estimates show that genetic 
predisposition has a large impact on mental health, but perhaps surprisingly, innate ability (as measured 
by the education PGS) is not significantly associated with mental health. Specifically, a 1 standard 
deviation increase in the PGS for depression is associated with a 0.359 unit (6.2%) increase in the CES-
D score, and a 2.3 percentage point (15.33%) increase in the incidence of depression. In contrast, the 
education PGS is negatively associated with mental health, but it is statistically insignificant. 
Estimates for elderly individuals from the HRS are given in Table 2 columns 4-6. The regressions 
control for a PGS for depression, a PGS for educational attainment, gender, age, age squared, mother’s 
education, and the first 10 ancestry-specific principal components of the genome wide data. The 
association between BMI and mental health is larger for the elderly than for young adults. For example, 
in column 4, a 5 kg/m2 increase in BMI is associated with a 0.145 unit increase in the CES-D score, and a 
1.5 percentage point increase in the probability of depression.  This is equivalent to a 11.5% and 12.5% 
increase in CES-D score and incidence of depression, respectively, relative to the corresponding sample 
means. The association between BMI and mental health does not differ substantially between elderly 
men and women. Estimates in columns 5 and 6 show that a 5 kg/m2 increase in BMI is associated with a 
10.49% (12.62%) increase in the CES-D score and a 14.29% (16.67%) increase in the probability of 
depression score for women (men). Finally, it is interesting to note that compared to young adults (i) the 
impact of genetic predisposition for depression in old age is larger, and (ii) innate ability as measured by 
the education PGS is significantly associated with better mental health for the elderly (except for men in 
panel B). For example, the coefficient on the depression (education) PGS in column 4 of panel A indicates 
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that, a 1 standard deviation increase in the PGS for depression (education) is associated with a 10.31% 
(6.74%) increase (decrease) in the CES-D score relative to the sample mean15.   
4.2 IV Estimates 
 The OLS estimates of 𝛽𝛽 could be biased because of unobserved factors that affect both BMI and 
mental health. We now turn to IV estimates, using the PGS for BMI as the instrument. Recall that IV 
estimates identify a different parameter from OLS. Under heterogeneous effects, IV estimates represent 
a LATE for individuals whose treatment (BMI) is affected by the instrument (PGS for BMI).  
Table 3 provides the first stage estimates. Column 1 presents results from an OLS regression of 
BMI on PGS for BMI and controls. It shows that a 1 standard deviation increase in the PGS for BMI is 
associated with a 1.803 (1.403) kg/m2 increase in the BMI of young adults (elderly individuals, 
respectively), with a first stage F-statistic of 289 (529). The PGS for BMI thus satisfies assumption A2 
(non-zero first stage effect). Columns 2-6 of Table 3 give estimates from conditional quantile regressions 
of BMI on PGS for BMI and controls. These estimates serve a number of purposes. First, they allow us to 
learn about the heterogeneity of the effect of our instrument (PGS for BMI) on our treatment variable 
(BMI). Second, they can provide indirect evidence about the monotonicity assumption (A3). Lastly, they 
provide our first suggestive evidence to characterize the effect that the IV estimates identify in our 
application. We observe that the effect of the PGS for BMI on all the selected quantiles of the conditional 
BMI distribution is positive and highly statistically significant. This is consistent with assumption A3, 
which states that the effect of the BMI PGS on BMI is non-negative for all individuals, thus providing 
                                                          
15 The OLS estimates without the depression and education PGS controls are similar to those in Table 2 (see appendix table 
A1). 
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indirect evidence in its favor (although not implying it holds, as the assumption is not directly testable)16. 
Also observed is a pattern of increasing conditional quantile estimates as one moves to higher quantiles, 
indicating that the IV has stronger effects on higher quantiles of the conditional BMI distribution. 
To shed additional light on how to interpret the effect identified by the IV estimates in our setting, 
we conduct an exercise similar in spirit to that in Angrist & Imbens (1995). In a setting with a binary IV 
and a treatment with variable intensity, they show that IV estimates identify a weighted average of 
treatment effects for those individuals whose treatment intensity is affected by the instrument (the 
compliers), where the weights are proportional to the (unconditional) quantile treatment effects (QTEs) 
of the IV on the treatment17. Intuitively, such weights allow to characterize the parameter identified by 
IV estimates, since the effects for those individuals (or compliers) with larger weights contribute more to 
the effect that is estimated with the binary IV. To implement this exercise using our continuous IV, we 
create a binary IV equal to 1 if the (standardized) PGS for BMI is greater than 0. We then estimate 
unconditional QTEs using the approach by Firpo (2007).  First, we estimate a propensity score by 
running a logit regression of the IV on the control variables. Next, we perform a weighted quantile 
regression using the propensity score to form individual weights18. The unconditional QTEs for Add 
Health and the HRS are shown in Figure 1. The unconditional QTEs are clearly larger at higher quantiles. 
For example, in the HRS there is a 2.20 kg/m2 difference in BMI between treated (PGS for BMI>0) and 
                                                          
16 In particular, note that the monotonicity assumption in A3 is imposed on the individual-level effect of the PGS for BMI on 
BMI, while quantile regression provides effects on the quantiles of the conditional distribution of BMI (rather than on the 
distribution of individual effects).  
17 Technically, the weights defined in Angrist & Imbens (1995) are proportional to the difference between the CDF of the 
potential treatment intensities in the absence of the IV (i.e., the treatment intensities that individuals would receive if Z=0) 
and the CDF of the potential treatment intensities under receipt of the IV (i.e., the treatment intensities that individuals would 
receive if Z=1). The result in Angrist & Imbens (1995) can be written in such a way that the weights are defined in terms of 
the difference in quantiles of those CDFs, which equal the unconditional QTEs we employ here.   
18 The weights=(z/phat) + ((1-z)/(1-phat)) where z is the binary instrument and phat is the predicted probability from the 
estimated propensity score model. 
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untreated individuals at the 60th percentile of the BMI distribution. At the 70th (80th) percentile the 
difference in BMI is 2.60 kg/m2 (2.80 kg/m2). This suggests that the groups of individuals that contribute 
the most to the IV estimate are those in the upper quantiles of the BMI distribution for both young adults 
and the elderly, implying that for both demographic groups the IV estimate reflects the effect of BMI on 
mental health mostly for individuals in the upper quantiles of the BMI distribution. It is important to keep 
this information present when the IV estimates are interpreted, since they likely identify the effect—
under the IV assumptions—for a subpopulation in which individuals on the upper quantiles of the BMI 
distribution have considerably more weight.  
The IV estimates are presented in Table 4. All the IV estimates for the effect of BMI for young 
adults are statistically insignificant and relatively small in magnitude, suggesting that there is no causal 
relationship between BMI and mental health. In comparison, the IV estimates for elderly individuals are 
statistically significant and large in magnitude. For example, IV estimates in column 4 indicate that a 5 
kg/m2 increase in BMI is associated with a 0.255 (20%) increase in the CES-D score, and a 3.57 
percentage point (29%) increase in the probability of depression. There are no statistically significant 
gender differences. For completeness, appendix Table 2 presents IV estimates using a dummy variable 
equal to 1 if the BMI PGS is greater than 0 as the instrument. The IV estimates using the binary instrument 
are not substantially different from those in Table 4. 
It is important to note that the IV estimates appear to be overestimated when models do not 
control for the education and depression PGSs, which is consistent with DiPrete et al.’s (2018) argument 
that the inclusion of the outcome’s PGS may reduce the consequences of pleiotropy. More concretely, 
the change in the IV estimates occurs because the education and depression PGSs are correlated with the 
BMI PGS (see footnote 11), which means that the instrument picks up some of the effects of these two 
PGSs when they are omitted. This point is illustrated in Table 5, which presents IV estimates without 
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controlling for the education and depression PGSs. The IV estimates are considerably larger in the HRS 
without adjusting for the education and depression PGSs, although the differences in coefficients are not 
statistically significant. For example, the effect of BMI on CES-D score (depression) when controlling for 
the PGSs in Table 4 column 4 is 0.051 (0.007). In contrast, the effect of BMI on CES-D (depression) 
when not controlling for them in Table 5 column 4 increases to 0.065 (0.009), giving a percentage 
increase of 27% (29%). In Add Health, the IV estimates appear overestimated to a lesser extent. The 
effect of BMI on CES-D score when adjusting for the education and depression PGSs is 0.020 in Table 4 
column 1. The corresponding IV estimate without controlling for the education and depression PGSs in 
Table 5 column 1 is 0.024, giving a percentage increase of 20%. However, the IV estimates for 
depression in Tables 4 and 5 are the same. 
Finally, we note that even with the inclusion of the depression and education PGSs, the BMI PGS 
may still violate the ER assumption through other channels. To complement the evidence presented thus 
far, we employ the alternative approach of obtaining an upper bound for the average effect of BMI on 
mental health for the corresponding population. 
4.3 Nevo & Rosen (2012) Bound Estimates 
In this subsection, we present evidence about the effect for the population parameter 𝛽𝛽 in  
equation (1) by using the BMI PGS as a potentially imperfect IV based on the approach by Nevo & Rosen 
discussed in section 3.2. Recall, that since (i) our IV (BMI PGS) is positively correlated with the 
endogenous variable (BMI), and (ii) the IV and endogenous variable are assumed to be positively 
correlated with the error term in equation (1)  (see discussion in section 3.2), the Nevo & Rosen (2012) 
procedure yields an upper bound on 𝛽𝛽.  
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 Results for the CES-D score are presented in Table 6. Panel A shows results for young adults in 
Add Health. Columns 2 and 3 give the OLS and IV estimates from Tables 2 and 4. Column 4 shows the 
IV estimate using 𝑉𝑉(1) = 𝜎𝜎𝐵𝐵𝐵𝐵𝐼𝐼𝑃𝑃𝑃𝑃𝑃𝑃_𝐵𝐵𝑀𝑀𝐵𝐵 − 1𝜎𝜎𝑃𝑃𝑃𝑃𝑂𝑂_𝐵𝐵𝐵𝐵𝐼𝐼𝐵𝐵𝑀𝑀𝐵𝐵 as the instrument, which is an intermediate 
step in the Nevo & Rosen procedure. The estimated upper bound (the min of the OLS and IV estimates; 
see equation (4)) under (A4)—that the instrument has weakly the same direction of correlation with the 
error term as the endogenous variable—is given in column 5. The estimated upper bound, while not able 
to rule out a null effect, indicates that the largest value of the average effect of BMI on the CES-D score 
for the population of young adults (𝛽𝛽) is 0.02 (the IV estimate). Based on this largest possible value for 
the effect, a 5 kg/m2 increase in BMI would be associated with at most a 0.1 unit (1.7%) increase in the 
CES-D score. The upper endpoint of the 95% confidence interval on the bounded parameter is 0.05219. 
Looking at the OLS estimate, we see that it falls within the 95% confidence interval of the bounded 
parameter. Since they both undertake statistical inference on the same parameter, this implies that we 
cannot statistically rule out that the OLS estimate is unbiased for the true population average effect (𝛽𝛽). 
The estimated upper bounds also suggest there could be a gender difference in the effect of BMI on the 
CES-D score among young adults. In particular, for women, the estimated upper bound, which 
corresponds to the IV estimate, is consistent with a 5 kg/m2 increase in BMI increasing the CES-D score 
by at most 1.5%. For men, the estimated upper bound, which corresponds to the OLS estimate, is 
negative, although the 95% confidence interval on the bounded parameter straddles zero, implying that 
a null effect is possible. Column 6 gives the estimated upper bounds (the min of the IV and IV(1) 
estimates; see equation 5) when we add (A5)—that the instrument is less correlated with the error term 
                                                          
19 The estimation of the upper bound and the construction of confidence intervals on the bounded parameter in the Nevo & 
Rosen approach necessitates a non-standard procedure given that the bounds’ expression contains a minimum operator. The 
stata program we use (imperfectiv) follows Nevo & Rosen (2012), who employ a variant of the Chernozhukov et al. (2013) 
method.  
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than the endogenous variable. These estimated upper bounds turn out to be not much different from 
those in column 5 for young adults, the main difference being that the 95% confidence intervals on the 
bounded parameter are somewhat larger. 
Results for elderly individuals in the HRS are given in panel B of Table 6. The estimated upper 
bound on the average effect for the elderly population in column 5 corresponds to the OLS estimate 
(0.029), implying that a 5 kg/m2 increase in BMI would be associated with, at most, an 11.5% increase 
in the CES-D score. Thus, this estimated upper bound provides valuable information, as it rules out 
plausible larger effects. Compared to the IV estimate (0.051), the estimated upper bound is about half 
as large. Indeed, looking at the 95% confidence interval (on the bounded parameter) of 0.037, the IV 
point estimate is considerably larger. As mentioned before, this difference has implications for the ER 
assumption only under the overly restrictive assumption of homogeneous effects. Instead, under 
heterogeneous effects and maintaining the ER assumption, the implication is that the average effect of 
BMI on the CES-D score for compliers (within the elderly population) is larger than the average effect on 
the elderly population. This interpretation is consistent with the previously presented evidence that the 
IV estimate likely captures the effect mostly for individuals at the upper part of the BMI distribution, who 
likely experience larger effects of their BMI on their CES-D score. Contrary to the young adult 
population, the estimated upper bounds on the corresponding average effect for elderly women and men 
are very similar. Lastly, the estimated upper bounds that add (A5), shown in column 6, yield very similar 
conclusions to the results in column 5, although with the estimated upper bounds in column 6 being 
somewhat smaller.   
Results for depression are shown in Table 7. The patterns observed are similar to those 
documented in Table 6, although the differences in estimated upper bounds between young adults and 
the elderly are slightly less pronounced. Looking at the estimated bounds under (A4) in column 5, the 
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largest possible value for the (population) effect indicates that a 5 kg/m2 increase in BMI would be 
associated with at most a 6.6% increase in the probability of experiencing depression for the population 
of young adults. For the elderly population, the estimated upper bound is related to a corresponding 
increase of 12.5% in the probability of experiencing depression. Importantly, as before, these estimated 
upper bounds are able to rule out plausible larger effects. 
 Overall, the results from employing the Nevo & Rosen (2012) bounds—which yield an upper 
bound on 𝛽𝛽 in this setting—can be summarized as follows. First, the estimated bounds for the population 
of young adults reinforce the IV-based finding that their effect of BMI on mental health is at most small 
and arguably economically insignificant. Second, the estimated upper bounds are suggestive of 
economically significant effects of BMI on mental health for the elderly population. Third, for the elderly 
population, when we compare the estimated upper bound on 𝛽𝛽 with the IV estimate that maintains the 
ER assumption (and identifies a LATE), the former is about half the magnitude of the latter. If effects are 
heterogeneous, this is consistent with the IV estimate reflecting the effect for individuals (or compliers) 
mostly from the upper part of the BMI distribution, as documented in section 4.2, who likely experience 
larger effects of BMI on mental health. Fourth, since in general the OLS estimates are below the estimated 
upper bounds (and/or below the 95% confidence intervals on the bounded parameter), we cannot rule 
out the possibility that the former estimates are unbiased for the population average effect of BMI on 
mental health. Lastly, the estimated upper bounds for both young adults and the elderly are able to rule 
out plausible effects, and are thus informative. 
4.4  Other Analyses 
4.4.1 Obesity 
Our main analyses focus on BMI rather than obesity (BMI≥30) because the instrument affects 
mental health through variation in BMI across the BMI distribution, not just incidence in obesity. 
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Nevertheless, we have analyzed the relationship between obesity and mental health in Appendix Table 
A3. The results for obesity are qualitatively similar to the BMI results. For young adults, the IV estimates 
show no statistically significant relationship between obesity and mental health. For elderly individuals, 
the IV estimates indicate that there is a large positive relationship between obesity and mental health. 
Obese individuals have a higher CES-D score by 0.705 units (56% relative to the sample mean), and are 
10.2 percentage points (85% relative to the sample mean) more likely to be depressed than non-obese 
individuals. From the estimated Nevo & Rosen (2012) upper bounds shown in columns 3 and 6, the 
patterns already documented emerge. Noteworthy is that, when considering obesity, the difference 
between the estimated upper bounds and the IV estimates is generally larger, which is in line with the 
notion that the effect identified by the IV estimates presented in section 4.2 capture the effect of BMI on 
mental health mostly for individuals from the upper part of the BMI distribution, since here the treatment 
is defined as having a more extreme value of BMI (≥30). 
4.4.2 Reverse Causality and Mortality Attrition 
We have also examined whether the findings for elderly individuals are influenced by (i) reverse 
causality, and (ii) mortality attrition. To assess the influence of reverse causality, we estimated the effect 
of mental health on BMI using the PGS for depression as the IV. Unlike the PGS for BMI, which predicts 
both BMI (first-stage effect) and mental health (reduced-form effect), the PGS for depression only 
predicts mental health (first-stage effect). Appendix Table A4 shows OLS, IV, and upper bound 
estimates using the HRS sample. While OLS estimates are positive and statistically significant, IV 
estimates are statistically insignificant. The estimated upper bounds are negative with the 95% 
confidence interval on the bounded parameter straddling zero. The IV estimates and estimated upper 
bounds provide suggestive evidence that reverse causality is unlikely to be driving our results. A second 
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potential concern is that our estimates could be affected by mortality attrition, as genetic data is only 
available for HRS respondents who have survived until 2006. As a robustness check, we weighted the IV 
regressions with the inverse of the probability of living until 2006. The probabilities were the predicted 
values from a logit regression where the dependent variable was an indicator for being alive in 2006 on 
basic demographics (year of birth, gender), health (ever smoked, ever had diabetes, ever had heart 
disease, average BMI up to 2004, average CES-D score up to 2004, average self-reported health up to 
2004), and socioeconomic variables (years of education, mother’s education). As shown in Appendix 
Table A5, the IV estimates are qualitatively similar to those presented in Table 4. The one exception is 
that the effect of BMI on depression for women becomes statistically insignificant. 
4.4.3 Exploration of Some Mechanisms 
As discussed in the introduction, BMI is hypothesized to affect mental health through various 
channels, including health concerns and functional limitations (Himes 2000; Markowitz et al. 2008; 
Paolucci et al. 2018). A useful discussion of different mechanisms through which BMI could affect mental 
health is provided in Willage (2018). Appendix Table A6 presents estimates (OLS, IV and bounds) of 
the effect of BMI on the following self-reported outcomes for the elderly: (i) probability of being in very 
good/excellent health, (ii) probability of engaging in vigorous exercise more than once per week, and (iii) 
probability of reporting that health limits at least 1 daily activity. Note that, as the outcome changes in 
these exercises, the conditions to obtain a lower or upper bound using the Nevo & Rosen (2012) 
approach may change. The rationale for justifying the direction of correlation between the error term 
corresponding to each of the outcomes in turn and the endogenous variable (BMI) and instrument (PGS 
for BMI) follows the same logic outlined in section 3.2. In panel A, we find evidence that BMI is linked to 
poor self-reported health. The IV estimate in column 3 suggest that a 5 kg/m2 increase in BMI is related 
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to a 9.5 percentage point (20%) decrease in the likelihood of reporting being in very good or excellent 
health. The estimated lower bound in column 4 (using (A4) and (A5)) is somewhat smaller (in absolute 
value) than the IV estimate. Unfortunately, the estimated lower bound does not allow ruling out a null 
effect since it is negative, but it allows ruling out effects from a 5 kg/m2 increase in BMI greater than 16%. 
This estimated effect is present in both women and men. In panel B, we see that, according to the IV 
estimate, a 5 kg/m2 increase in BMI is related to a 6.5 percentage point (25%) decrease in the likelihood 
of engaging in vigorous exercise more than once per week. The estimated lower bound is smaller than the 
IV estimate (in absolute value), and cannot be used to rule out a null effect. This estimated effect is also 
present in both women and men. Looking at panel C, the IV estimate suggests that a 5 kg/m2 increase in 
BMI is related to a 5 percentage point (42%) increase in the likelihood of reporting that health limits at 
least 1 daily activity. For this outcome, we obtain an upper bound, which is estimated to be just slightly 
smaller than the IV estimated effect. According to the estimated upper bound, the effect is at most 38% 
for the elderly population. Based on these results, it appears that health concerns are plausible 
mechanisms through which BMI has an impact on mental health for elderly individuals. 
5. Conclusion 
We examine the relationship between BMI and mental health for young adults in Add Health and 
elderly individuals in the HRS. To account for confounding due to unobserved factors and reverse 
causality, we first take the same approach as previous studies (Hung et al. 2014; Jokel et al. 2012; Tyrrell 
et al. 2018; Walter et al. 2015; Willage 2018) and use a PGS for BMI as an IV. However, unlike the 
previous studies, our PGS is more powerful because it is based on the more recent GWAS by Locke et al. 
(2015) and includes all SNPs, rather than just genome-wide significant SNPs. Moreover, we attempt to 
address the possible violation of the exclusion restriction (ER) assumption due to pleiotropy by using 
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PGSs for depression and education to control for the genetic predisposition to poor mental health and 
innate ability. We also contribute to this literature by analyzing effects of the IV on the BMI quantiles. 
We document that IV estimates, which identify a weighted average of effects for individuals whose BMI 
is affected by their BMI PGS (the compliers), are likely to capture the effect of BMI on mental health 
mostly for individuals in the upper quantiles of the BMI distribution. As a second approach to account for 
unobserved confounding and reverse causality, we estimate an upper bound on the average treatment 
effect for the corresponding population (i.e., on the parameter identified by OLS, 𝛽𝛽 in equation (1)). We 
use the approach of Nevo & Rosen (2012), which has not been used in this context as far as we are aware. 
The attractiveness of this approach is to employ the PGS for BMI as a potentially “imperfect” instrument 
that may not satisfy the ER assumption, instead imposing relatively weaker conditions about the 
direction of certain correlations. 
For young adults, the IV estimates indicate that there is no statistically significant relationship 
between BMI and mental health. The estimated upper bounds are consistent with the notion that the 
effect of BMI on mental health for young adults is at most small and economically insignificant. The results 
for young adults are consistent with those in Willage (2018), who also used Add Health, but with a 
smaller sample and less powerful PGS. In contrast, the IV estimates for elderly individuals are statistically 
and economically significant. They indicate that a 5kg/m2 increase in BMI (a difference equivalent to 
moving from overweight to obese) is related to a 20% increase in the CES-D score, and a 29% increase 
in the likelihood of depression. We find no statistically significant gender differences in the IV estimates. 
The estimated upper bounds are consistent with the IV estimates in that they are also suggestive of large 
and economically significant effects of BMI on mental health for the elderly population. These results do 
not support the “jolly fat” hypotheses (Crisp et al., 1980; Palinkas et al., 1996), which argues that BMI 
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has a protective effect on mental health for elderly individuals. Interestingly, for the elderly population, 
the IV estimates (which identify a weighted average of effects for compliers) are about twice as large as 
our estimated upper bounds on 𝛽𝛽. Under heterogeneous effects, this speaks to the notion that the effect 
for compliers is larger than the effect for the overall population. This same notion is supported by our 
estimates of the quantile treatment effects of the PGS for BMI on BMI, which suggest that the IV 
estimates identify the effect of BMI on mental health mostly for individuals from the upper part of the 
BMI distribution, who thus are likely to experience large effects of BMI on mental health.  
 Overall, our results suggest that policy interventions aimed at reducing obesity (e.g. the healthy 
food financing initiative) could have indirect benefits of improving mental health among the elderly. To 
put our estimates in perspective, Baicker et al. (2013) report that the Oregon Health Insurance 
Experiment (which randomly provided low-income uninsured adults access to Medicaid) reduced the 
probability of depression by 30%. Among individuals between age 50 and 64, this effect is larger at 
58%20. Our preferred results indicate that a reduction of 5kg/m2 in BMI—admittedly a substantial 
reduction—could have an impact on the incidence of depression of between one-seventh (based on our 
bounds estimates) and one-half (based on our IV estimates) of the effect of having access to health 
insurance. 
There are some limitations with our paper. First, we focus on European ancestry individuals 
because GWASs are mostly conducted on European descent populations. This means that PGSs for 
other ethnic groups may not have the same predictive power (Martin et al. 2017). We also do not look 
at the effect of BMI on mental health in midlife, which may differ from the effect found for young adults 
and elderly individuals.  
                                                          
20 Author’s own calculations with the public use data provided by Baicker et al. (2013), using their same specification to 
obtain LATE effects. The percentage effect is relative to the corresponding control mean. 
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Table 1: Summary Statistics 
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Table 2: OLS Estimates of the Effect of BMI on Mental Health in Young and Old Adults 
 
  
37 
 
Table 3: First Stage Estimates of the Effect of the BMI PGS on BMI 
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Figure 1: Unconditional Quantile Treatement Effects of the Binary IV on BMI
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Table 4: IV Estimates of the Effect of BMI on Mental Health in Young and Old Adults 
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Table 5: IV Estimates of the Effect of BMI on Mental Health in Young and Old Adults 
without Controlling for PGSs for Depression and Educational Attainment 
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Table 6: OLS, IV and Upper Bounds for the Effect of BMI on CES-D Score 
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Table 7: OLS, IV and Upper Bounds for the Effect of BMI on Depression 
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Appendix Table A1: OLS Estimates of the Effect of BMI on Mental Health in Young and 
Old Adults without Controlling for the Depression and Education PGSs 
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Appendix Table A2: IV Estimates of the Effect of BMI on Mental Health in Young and 
Old Using a Binary Instrument 
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Appendix Table A3: OLS, IV and Upper Bounds for the Effect of Obesity on Mental Health 
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Appendix Table A4: The Effect of Mental Health on BMI for Old Adults 
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Appendix Table A5: IV Estimates of the Effect of BMI on Mental Health for Old Adults, 
Accounting for Mortality Attrition 
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Appendix Table A6: Effect of BMI on Health and Exercise for Older Adults 
 
 
